When will adagrasib be available in China?

Adagrasib (Adagrasib) is not yet available in China. However, once a drug completes clinical trials and is approved by China's National Medical Products Administration (NMPA), it may be available in China.

Typically, the time it takes for a drug to be launched in China depends on several factors, including clinical trial results, the drug approval process, regulatory review times, and production and supply chain preparations. Clinical trials for adagrasiib may take some time to collect and analyze data to evaluate its efficacy and safety in the Chinese patient population.

Once clinical trial data are sufficient and relevant regulatory requirements are met, the pharmaceutical company will submit an application in the hope of obtaining ChinaNMPA approval. NMPAwill review the quality, safety and effectiveness of drugs and may discuss the drug's labeling, indications and instructions for use with pharmaceutical companies. Once approved, pharmaceutical companies can sell and promote the drug in the Chinese market.

Given the complexity of drug launches and the uncertainty of the approval process, it is difficult to predict the exact time when adagrasib will be launched in China. However, with China's continued investment in the field of oncology treatment and the continuous demand for innovative drugs, many new drugs usually submit marketing applications as soon as possible after successful clinical trials and try their best to speed up the approval process.

Therefore, although it is impossible to determine when adagrasib will be launched in China, as China's drug approval process continues to improve and accelerate, patients are expected to have access to this new targeted drug treatment option as early as possible in the future.

Adagrasib is not yet available in China, so patients cannot purchase it domestically and need to purchase adagrasib through overseas channels. The foreign original drug of adagrasib is mainly the original American drug, which is very expensive. The price is more than 180,000 yuan, which is simply unaffordable for ordinary families. Fortunately, foreign generic drugs have been on the market recently, mainly the Laos Lucius Adagrasibu generic drug. A box only costs about 4,000 to 5,000 yuan, and the ingredients of the original drug and the generic drug are basically the same.